Categories: Miscellaneous

Weekly Picks 12th February 2024

1.SBIN LTP 724

CounterSBIN LTP 724
CallBuy on dip
Target 1780
Target 2820
Stop LossBelow 675
Time Horizon2-3 weeks
NotesBuy on dip around 705 Avg. 685

State Bank of India (SBI) a Fortune 500 company, is an Indian Multinational, Public Sector Banking and Financial services statutory body headquartered in Mumbai. The rich heritage and legacy of over 200 years, accredits SBI as the most trusted Bank by Indians through generations.

SBI, the largest Indian Bank with 1/4th market share, serves over 48 crore customers through its vast network of over 22,405 branches, 65,627 ATMs/ADWMs, 76,089 BC outlets.

Previous Close699.6TTM EPS72.71
52 Week High728.35TTM PE9.97
52 Week Low499.35P/B2.21
Sector PE15.82Mkt Cap (Rs. Cr.)647,257
(Source: Moneycontrol, BSE, Fisdom Research)

Technical Outlook

(Source: Fisdom research)

  • The counter witnessed a consolidation break-out above the 625-650 zone & scaled to “Fresh All Time” highs of 730 last week
  • The counter has an immediate minor hurdle at around 740 odd levels, followed by higher positional targets of 780 & 820 levels in the mid-term time frame.
  • In short-term outlook remains “Buy-On-Dip” towards 705 & 685 levels for 740 & next higher 780 odd levels.

Option Chain Study

  • Derivative Option Chain data indicates “Tug-Of-War” at around 700 Strike rates.
  • Maximum CE build-up is at 650 & 700 Strike while maximum PE build-up is at 650 Strikes. Dips towards 700 & lower can provide a fresh, better risk-reward ratio for fresh trading long bets.

F&O Strategy

ScripSBIN LTP 724
RiskModerate
Ratio1:2
BiasRange to positive bias
Max Reward Expected~Rs. 96,150
Max Risk Expected~Rs. 23,850
ActionScripQuantityEntry PriceLTP
BUYSBIN FEB 720 CE150024.824.8
SELLSBIN FEB 800 CE30004.454.45
Invest Now

2.DRREDDY LTP 6152

CounterDRREDDY 6152
CallBuy on dip
Target 16400
Target 26650
Stop LossBelow 5850 on close
Time Horizon2-3 weeks
NotesBuy on dip around 6050 & Avg 5950

Dr Reddy’s Laboratories Ltd products and services are spread across our core businesses of Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and over-the-counter pharmaceutical products around the world.

Previous Close6160.0TTM EPS313.42
52 Week High6220TTM PE19.64
52 Week Low4297P/B5.33
Sector PE54.40Mkt Cap (Rs. Cr.)102,685
(Source: Moneycontrol, BSE, Fisdom Research)

Technical Outlook

(Source: Fisdom research)

  • The counter witnessed a six-month consolidation break-out above 6000 levels & made “Fresh All Time” highs of 6216 last week.
  • The counter short-term hurdles are at around 6400 & 6650 levels, followed by higher positional targets of 7000 levels in the mid-term time frame.
  • In short-term outlook remains “Buy-On-Dip” towards 6000 & 5850 levels for 6400 & next higher 6650 odd levels.

Option Chain Study

  • Derivative Option Chain data indicates “Tug-Of-War” at around 6000 Strike rates.
  • Maximum CE build-up is at 6200 & 6000 Strike while maximum PE build-up is at 6000 & 5500 Strikes. Dips towards 6000 & lower can provide a better risk-reward ratio for fresh trading long bets.
  • Proportionate delivery buying or Long Hedged Ratio Spread can be looked at on dips in coming weeks for potential higher targets.

F&O Strategy

ScripDRREDDY 6152
RiskModerate
Ratio1:1
BiasRange to positive
Max Reward Expected~Rs. 40,144
Max Risk Expected~Rs. 22,500
ActionScripQTYEntry PriceLTP
BUYDRREDDY FEB 6000 CE125217217
SELLDRREDDY FEB 6500 CE12538.1538.15
Invest Now

Disclaimer: This document is not intended for anyone other than the recipient. The contents of this document may not be reproduced or further distributed to any person or entity, whether in whole or in part, for any purpose. If you have received the publication in error please notify the sender immediately. If you are not the named addressee, you should not disseminate, distribute or copy this document. You are hereby notified that disclosing, copying, distributing or taking any action in reliance on the contents of this information is strictly prohibited. All non-authorised reproduction or use of this document will be the responsibility of the user and may lead to legal proceedings. This document has no contractual value and is not and should not be construed as advice or as an offer or the solicitation of an offer or a recommendation to take action in consonance in any jurisdiction. Finwizard Technology Private Limited (“Fisdom”) makes no guarantee, representation or warranty and accepts no responsibility or liability for the accuracy or completeness of the information and/or opinions contained in this document, including any third party information obtained from sources it believes to be reliable but which has not been independently verified. In no event will Fisdom be liable for any damages, losses or liabilities including without limitation, direct or indirect, special, incidental, consequential damages, losses or liabilities, in connection with your use of this document or your reliance on or use or inability to use the information contained in this document, even if you advise us of the possibility of such damages, losses or expenses. Fisdom does not undertake any obligation to issue any further publications or update the contents of this document. The information stated and/or opinion(s) expressed herein are expressed solely as general commentary for general information purposes only and do not constitute advice, solicitation or recommendation to act upon thereof. Fisdom does not have regard to specific investment objectives, financial situation and the particular needs of any specific person who may receive this document. The information contained within this document has not been reviewed in the light of your personal circumstances. Please note that this information is neither intended to aid in decision making for legal, financial or other consulting questions, nor should it be the basis of any investment or other decisions. Fisdom may have issued other similar documents that are inconsistent with and reach different conclusion from the information presented in this document. The relevant offering documents should be read for further details. You should make such researches/inspections/inquiries as it deems necessary to arrive at an independent evaluation of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks involved. Fisdom makes no representations that the offerings mentioned in this document are available to persons of any other country or are necessarily suitable for any particular person or appropriate in accordance with their local law. Among other things, this means that the disclosures set forth in this document may not conform to rules of the regulatory bodies of any other country and investment in the offer discussed will not afford the protection offered by the local regulatory regime in any other country. Past performance contained in this document is not a reliable indicator of future performance whilst any forecasts, projections and simulations contained herein should not be relied upon as an indication of future results. The historical performance presented in this document is not indicative of and should not be construed as being indicative of or otherwise used as a proxy for future or specific investments. The relevant product documents should be read for further details. Fisdom does not undertake any obligation to issue any further publications to you or update the contents of this document and such contents are subject to changes at anytime.

Fisdom Research

Share
Published by
Fisdom Research

Recent Posts

Diwali Picks 2024

This Diwali, we present a portfolio that reflect both sector-specific and stock-specific opportunities. With 2…

2 months ago

Expert Recommended Stocks

Thank you for showing interest in taking a BTST position using our Delivery Plus product.…

5 months ago

Congratulations! Your FREE session with our expert is confirmed.

Thank you for showing interest in the consultation on trading strategies! Our expert will reach…

8 months ago

How to sell shares of unlisted companies?

Even if you are a new participant in the stock market, the process of buying…

1 year ago

Interest Coverage Ratio – Meaning, Types, Interpretation & Importance

A company’s debt position can be gauged using the interest coverage ratio or ICR. This…

1 year ago

Muhurat trading timings 2023-24: Indian stock exchanges

Muhurat Trading, a cherished tradition in the Indian stock market, takes place on Diwali, the…

1 year ago